drugset / Trial / NCT04615611

Physiologic Performance Response to Salbutamol

NCT04615611

Unknown 20 enrolled University of Copenhagen
RandomizedCrossoverTriple-blindBasic science

Summary

This project aims to investigate the individual physiological response to beta2-adrenergic stimulation with salbutamol on performance-related outcomes

Timeline

Start
2020-11-07
Primary completion
2021-11-07
Completion
2021-11-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Salbutamol Unknown 800 ug Inhaled

Indications

No indication recorded.